News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
It is estimated that one American develops Alzheimer’s Disease every 65 seconds, with that rate projected to accelerate. Current approaches to treating Alzheimer’s focus on helping people maintain mental function, manage behavioral symptoms, and slow down the symptoms of the disease, but there is
As the largest basic science research institute in the world, it can be daunting to find out how to access the opportunities for businesses available at NIH. On September 22, 2020 BioNJ is hosting a webinar featuring the National Cancer Institute’s Michael Salgaller to discuss how to collaborate
Interested in expanding your knowledge base? Registration for the Foundation for Advanced Education in the Sciences (FAES) Fall 2020 courses at NIH are now open. The Fall semester is offering courses in Biology, Chemistry, Bioinformatics, Immunology, Languages and General Studies, Microbiology